Allergy · Beats · Immunotherapy · Multiallergen · Multifood · Omalizumab · Oral · Trial

Omalizumab beats multiallergen oral immunotherapy in multifood allergy trial

Covered by 1 of 116 currently active countries' press · not covered by: United Arab Emirates, Afghanistan, Algeria, Azerbaijan, Albania, Armenia, Angola, Argentina, Australia, Austria, Bahrain, Belgium…